Industrial internationalization of the fully integrated“R&D-Manufacturing-Commercialization”value chain, establish a hub for innovative drugs to enter emerging overseas markets

Emerging markets such as Southeast Asia and the Middle East are experiencing a critical phase of accelerated pharmaceutical demand, driven by large population bases, expanding middle-class segments, aging demographics, improving healthcare infrastructure, and increasing chronic disease burden. These regions have become new growth engines for the global pharmaceutical industry. With over three decades of development, CMS has built a rich portfolio of differentiated products and mature commercialization capabilities in the China market. These advantages and capabilities are now spilling over into emerging markets.

Since 2022, CMS has advanced its “industrial internationalization” strategy by establishing Singapore as its hub for emerging markets in the Asia-Pacific region. The Group has built a fully integrated ecosystem comprising CMS R&D (research), PharmaGend (manufacturing), and Rxilient (commercialization), and further establish a synergistic Asia-Pacific platform, to seize the mid- to long-term structural opportunities and significantly enhance drug accessibility in these regions.

Main Marketed Products

EyeOP1 Glaucoma Treatment Device (exclusive product)

Indication
Glaucoma with intraocular pressure that cannot be controlled by drugs and surgery

 

Combizym (Oryz-aspergillus Enzyme and Pancreatin Tablets) (exclusive product)

Indication
Dyspepsia caused by a decrease in digestive enzymes

The information on this page is only for the introduction of the medicines and medical devices to partners or medical professionals, not for product advertising. The product information on this website shall not replace medical advice and medical consultation provided by doctors or other qualified medical professionals, and shall not be used for disease diagnosis. For detailed information about the medicines and medical devices, please refer to the latest product instructions. If you have understood and confirmed the above content, please click OK to enter.